Clinical Trials on Secondary Adrenal Insufficiency
Total 18717 results
-
University of Roma La SapienzaCompletedSecondary Adrenal Insufficiency | Primary Adrenal InsufficiencyItaly
-
Hopital La RabtaActive, not recruitingSecondary Adrenal Insufficiency | Fasting, IntermittentTunisia
-
Chronic Obstructive Pulmonary Disease Trial Network...Rigshospitalet, DenmarkCompleted
-
University Medical Center GroningenCompletedAdrenal InsufficiencyNetherlands
-
HaEmek Medical Center, IsraelCompletedSecondary Adrenal InsufficiencyIsrael
-
Genzyme, a Sanofi CompanyCompletedRenal Failure | Secondary Hyperparathyroidism | Chronic Renal InsufficiencyUnited States, Puerto Rico
-
AmgenCompletedSecondary Hyperparathyroidism | Chronic Renal Insufficiency
-
OPKO Health, Inc.CompletedVitamin D Insufficiency | CKD Stage 4 | CKD Stage 3 | Secondary Hyperparathyroidism Due to Renal CausesUnited States
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyCanada, United States
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyUnited States
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
AmgenCompletedSecondary Hyperparathyroidism, Chronic Kidney DiseaseUnited States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
-
AmgenTerminatedChronic Kidney Disease, Secondary HyperparathyroidismUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
-
AmgenCompletedChronic Kidney Disease, Secondary HyperparathyroidismBelgium, United States, Germany, Poland, United Kingdom, Lithuania
-
OPKO Health, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Vitamin D InsufficiencyUnited States
-
The University of Hong KongAbbVieUnknownSecondary Hyperparathyroidism | Endstage Renal DiseaseHong Kong
-
SanofiActive, not recruitingSecondary Hyperparathyroidism-Chronic Kidney DiseaseUnited States, Chile
-
AbbVie (prior sponsor, Abbott)CompletedEnd Stage Renal Disease | Secondary HyperparathyroidismTurkey
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
AmgenCompletedSecondary Hyperparathyroidism in Patients With ESRD on HemodialysisUnited States
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
TheraclionWithdrawnEnd Stage Renal Disease | Secondary Hyperparathyroidism | Parathyroid HyperplasiaSpain, Italy
-
Mahidol UniversityCompletedEnd Stage Renal Disease | Secondary HyperparathyroidismThailand
-
AbbVie (prior sponsor, Abbott)CompletedSecondary Hyperparathyroidism | Kidney InsufficiencyAustria, Germany
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyUnited States
-
Chengdu Suncadia Medicine Co., Ltd.Not yet recruiting
-
AbbVie (prior sponsor, Abbott)CompletedEvaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)Chronic Kidney Disease | Secondary HyperparathyroidismBulgaria, Czech Republic, Romania
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Kidney Disease
-
AmgenCompletedEnd Stage Renal Disease
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, Taiwan, Hong Kong, China, India, Malaysia
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, SecondaryUnited States, Germany, United Kingdom
-
AbbottCompletedHemodialysis | Chronic Kidney Disease | Secondary HyperparathyroidismUnited States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
-
ENRICO VERRINAUnknownSecondary HyperparathyroidismItaly
-
AbbottCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
AbbVie (prior sponsor, Abbott)CompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AbbottAbbott Japan Co.,LtdCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Secondary Hyperparathyroidism | Stage 5 Chronic Kidney Diseases
-
AbbottCompletedEnd Stage Renal Disease | Secondary HyperparathyroidismUnited States
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney FailureGreece
-
AbbVie (prior sponsor, Abbott)AlmedisCompletedSecondary HyperparathyroidismRussian Federation
-
Atlanta VA Medical CenterEmory UniversityCompletedKidney DiseaseUnited States
-
AbbottCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
Washington University School of MedicineAbbott; NorthShore University HealthSystem; Northwestern University Feinberg... and other collaboratorsCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AbbottAbbott Japan Co.,LtdCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease on HemodialysisJapan
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism
-
University of Colorado, DenverCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States